It is still very difficult to understand why this stock is susceptible to such wild price gyrations--in less than 10 minutes this morning it dropped more than $1. Is this due to lack of conviction on the part of buyers? Is it being manipulated by shorts? But then again the question is with such strong fundamentals why is it such an easy prey for the shorts?
onxx has always been volatile; after nexavar got fda nod sometime back, stock price gyrated quite a bit. I try to ignore the daily price changes. We are just getting started with Kyprolis and Stivarga and then there is the breast cancer pipeline (good 8% royalty from pfizer and nexavar trial). I am expecting to see this cross analyst targets ($105) in coming months. Would like to see onxx be the next gild or celg..